Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Bloodstream-associated Salmonella Typhimurium and Enteritidis iNTS pathovariants hyper-replicate in human macrophages [version 1; peer review: awaiting peer review]

Дата публикации: 15-09-2026 11:57:34

Background Invasive non-typhoidal Salmonella (iNTS) are a major cause of bloodstream infections in sub-Saharan Africa, yet the mechanisms that allow iNTS bacteria to survive within human cells remain poorly understood. Macrophages represent a key intracellular niche for Salmonella during systemic infection, and a reproducible human model for iNTS is required to compare pathovariants behaviour. Methods A human macrophage infection model was developed and optimized based on PMA-differentiated THP-1 cells to investigate infection dynamics of clinically relevant Salmonella Typhimurium and Salmonella Enteritidis strains. We compared intracellular survival and replication of gastroenteritis-associated and bloodstream-associated pathovariants, including S. Typhimurium ST313 Lineage 2, the novel S. Typhimurium ST313 Lineage 3 and the understudied S. Enteritidis Central/Eastern African (CEAC) clades. Bacterial uptake and intracellular replication were distinguished by gentamicin protection assay and confocal microscopy. Macrophage activation state was assessed to determine the capacity of the model to reproduce pro-inflammatory polarisation and macrophage plasticity. Results CEAC S. Enteritidis and ST313 S. Typhimurium iNTS pathovariants hyper-replicate within human macrophages compared to global epidemic isolates, identifying a shared intracellular phenotype. The cellular model achieved robust pro-inflammatory polarisation of human macrophages, while revealing limitations in modelling macrophage plasticity. Conclusions Intracellular behaviour differs between Salmonella pathovariants, and enhanced replication within human macrophages is shared by African iNTS lineages of both serovars, Typhimurium and Enteritidis. The optimised THP-1 model provides a reproducible framework for dissecting invasive disease pathogenesis and evaluating therapeutic strategies against iNTS bacteria.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Surveillance-Driven Machine Learning for Prediction of Antimicrobial Susceptibility: An Explainable Modeling Framework using the Pfizer ATLAS Dataset (2004 - 2023) [version 2; peer review: 2 approved, 1 not approved]013.8821-09-2026
2A phase IV parallel-group, open-label, randomized non-inferiority trial evaluating immunogenicity of extended dosing intervals for Euvichol-S oral cholera vaccine in Nairobi, Kenya: study protocol for a randomized non-inferiority trial [version 1; peer review: awaiting peer review]014.1428-09-2026
3Evaluating the 7-1-7 Outbreak Response Metric: Modelling and Implementation Insights for Ebola, Measles, and Anthrax in Central and Eastern Uganda, 2025 [version 2; peer review: 2 approved with reservations]011.412-09-2026
4Strengthening systems to monitor antibiotics. An action oriented approach [version 2; peer review: 1 approved, 2 approved with reservations]08.2524-09-2026
5The “readily available” second-line antibiotics are more cost-effective than the “easily accessible” first-line antibiotics as the initial management of Urinary Tract Infections and Chorioamnionitis in Malawi [version 2; peer review: 2 approved with reservations]09.6417-09-2026
6Process mapping of a collaborative quality improvement study to optimise the use of antibiotics in intensive care units in Argentina: a Pathfinder study [version 2; peer review: 1 approved]06.8322-09-2026
7How a single viral protein hijacks immune cells to supercharge COVID-19 infection08.2118-09-2026
8Antiviral activity of new organophosphorus compounds <i>in vitro</i>06.6229-06-2026
9В России создали добавки для повышения эффективности антибиотиков010.5528-09-2026
10Опасное заблуждение! Мясников поставил точку: надо ли мыть куриные яйца01028-09-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.9. Источник: wellcomeopenresearch.org.